A New FDA Approval Brings New Psychiatric Risks

16:43 | Sep 1st

The FDA just approved the cyclobenzaprine (Tonmya, Flexeril) for fibromyalgia. We look at three risks that medication raises in psychiatry.CME: Take the CME Post-Test for this Episode (https://www.the...Show More